Chinook Therapeutics Inc (NASDAQ:KDNY)

Delayed Data
As of Oct 03
 +0.09 / +0.46%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Chinook Therapeutics Inc have a median target of 32.00, with a high estimate of 44.00 and a low estimate of 20.00. The median estimate represents a +62.03% increase from the last price of 19.75.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Chinook Therapeutics Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 09

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -2.58%
Growthannually -8.15%


Growthquarterly -72.09%
Growthannually -93.57%
Key to the earnings and sales forecast charts.